XML 62 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restatement
9 Months Ended
Aug. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Restatement

Note 15 – Restatement

 

During 2014, the Company determined that it should have recorded and valued tainted derivatives that had not previously been identified as derivatives. As a result, the Company has restated its previously issued financial statements for the nine and three-month periods ended August 31, 2013. The restatement resulted in a gain of $656,535 for the nine-month period ended August 31, 2013, or a decrease of $658,013, as compared to a gain of $1,314,548 that had previously been reported, and a loss of $1,019,151 for the three-month period ended August 31, 2013, or a decrease $457,466, as compared to a loss of $561,685 that had previously been reported.

 

The Company restated its consolidated financial statements as of and for the nine months ended August 31, 2013 as follows:

 

   Nine Months Ended August 31, 2013
             
   As Originally Reported  Adjustments     As Restated
Interest expense  $587,856   $1,896,922   (1)  $2,484,778 
(Gain) loss on settlement of liabilities   —      (1,493,608)  (3)   (1,493,608)
(Gain) loss on value of derivative liabilities   (185,844)   254,699   (2)   68,855 
Other income   2,162,449    (658,013)      1,504,436 
Net income   1,314,548    (658,013)      656,535 

 

 

Adjustments to consolidated financial statements:

(1)To record debt discount on convertible debentures.
(2)To record derivative liabilities for tainted options and warrants.
(3)To record gain on the settlement of derivative liabilities.

 

The Company restated its consolidated financial statements as of and for the three months ended August 31, 2013 as follows:

 

    Three Months August 31, 2013
               
       As Originally Reported        Adjustments           As Restated  
Interest expense   $ 181,522     $ 626,670     (1)   $ 808,192  
(Gain) loss on settlement of liabilities     —         (149,282 )   (3)     (149,282 )
(Gain) loss on value of derivative liabilities     (60,178 )     (19,922 )   (2)     (80,100 )
Other income     (271,344 )     (457,466 )         (728,810 )
Net income     (561,685 )     (457,466 )         (1,019,151 )

 

Adjustments to consolidated financial statements:

(1)To record debt discount on convertible debentures.
(2)To record derivative liabilities for tainted options and warrants.
(3)To record gain on the settlement of derivative liabilities.